PRECEDE BIOSCIENCES
Live / Applied — Second extension granted (statement of use) (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 05 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98391995
- Mark type
- Stylized text
- Filed
- 05 Feb 2024
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Caitlin R. Byczko
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product
- Class 044 — Medical, beauty and agricultural services: medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states
Owner
- Precede Biosciences, Inc., Cambridge, MA, US
- Precede Biosciences, Inc., Boston, MA, US
Prosecution history
- 10 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2026 — SOU EXTENSION 2 GRANTED
- 10 Mar 2026 — SOU EXTENSION 2 FILED
- 10 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 1 GRANTED
- 19 Aug 2025 — SOU EXTENSION 1 FILED
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED